ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Zomedica Pharmaceuticals Corp

Zomedica Pharmaceuticals Corp (ZOM)

0.285
0.00
(0.00%)
Cerrado 01 Enero 3:00PM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
0.285
Postura de Compra
0.11
Postura de Venta
0.45
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.285
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
979,949,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-3.41
Beneficio por acción (BPA)
-0.04
turnover
25.19M
Beneficio neto
-34.53M

Acerca de Zomedica Pharmaceuticals Corp

Sector
Testing Laboratories
Industria
Unit Inv Tr, Closed-end Mgmt
Sitio web
Sede
Ann Arbor, Michigan, USA
Fundado
2016
Zomedica Pharmaceuticals Corp is listed in the Testing Laboratories sector of the TSX Venture Exchange with ticker ZOM. The last closing price for Zomedica Pharmaceuticals was $0.29. Over the last year, Zomedica Pharmaceuticals shares have traded in a share price range of $ 0.00 to $ 0.00.

Zomedica Pharmaceuticals currently has 979,949,000 shares in issue. The market capitalisation of Zomedica Pharmaceuticals is $279.29 million. Zomedica Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.41.

ZOM Últimas noticias

Sean Whelan Appointed to Board of Directors

ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Announces Second Quarter 2021 Financial Results

ANN ARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

Zomedica Announces 2021 Annual Meeting Results

ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

Zomedica Provides Corporate Update

FOCUSED ON TRUFORMA® INSTRUMENT PLACEMENTS AND BUILDING DIRECT SALES ORGANIZATION ANN ARBOR, Mich., July 06, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the...

Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts

Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities ANN ARBOR, Mich., May 17, 2021...

Zomedica Announces First Quarter 2021 Financial Results

ANN ARBOR, Mich, May 12, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company creating point-of-care diagnostics products for dogs...

Zomedica to Build Direct Sales Force for TRUFORMA® Platform

ANN ARBOR, Mich., April 15, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Announces First Commercial Sale of Its Truforma® Platform

ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Retires Preferred Shares

ANN ARBOR, Mich., March 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

Zomedica Corp. Announces Year End 2020 Financial Results

ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ZOM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Zomedica Pharmaceuticals?
El precio actual de las acciones de Zomedica Pharmaceuticals es $ 0.285
¿Cuántas acciones de Zomedica Pharmaceuticals están en circulación?
Zomedica Pharmaceuticals tiene 979,949,000 acciones en circulación
¿Cuál es la capitalización de mercado de Zomedica Pharmaceuticals?
La capitalización de mercado de Zomedica Pharmaceuticals es CAD 279.29M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals ha negociado en un rango de $ 0.00 a $ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Zomedica Pharmaceuticals?
El ratio precio/beneficio de Zomedica Pharmaceuticals es -3.41
¿Cuál es el ratio de efectivo a ventas de Zomedica Pharmaceuticals?
El ratio de efectivo a ventas de Zomedica Pharmaceuticals es 4.67
¿Cuál es la moneda de reporte de Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Zomedica Pharmaceuticals?
El último ingresos anual de Zomedica Pharmaceuticals es USD 25.19M
¿Cuál es el último beneficio anual de Zomedica Pharmaceuticals?
El último beneficio anual de Zomedica Pharmaceuticals es USD -34.53M
¿Cuál es la dirección registrada de Zomedica Pharmaceuticals?
La dirección registrada de Zomedica Pharmaceuticals es 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, MICHIGAN, 48108
¿Cuál es la dirección del sitio web de Zomedica Pharmaceuticals?
La dirección del sitio web de Zomedica Pharmaceuticals es www.zomedica.com
¿En qué sector industrial opera Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals opera en el sector UNIT INV TR, CLOSED-END MGMT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.31
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.31
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.31
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
glenn1919 glenn1919 55 segundos hace
pet............................https://stockcharts.com/h-sc/ui?&s=pet&id=p80904663129&listNum=4&a=1431976465
PET
ORCA ORCA 1 minuto hace
THE Same to you.Let;s hope this one and ILUS make a come back soon.IF these idiots try to screw us.They are Toast for ever.They have no freaken idea.
ILUS
luvwetscent luvwetscent 2 minutos hace
ok..thx
ELTP
DiscoverGold DiscoverGold 2 minutos hace
Gold Tests Trendline Resistance Amidst Bearish Channel Pressures
By: Bruce Powers | January 1, 2025

• Gold tests resistance at the declining trendline, but bearish pressures persist as the downtrend remains intact without a clear breakout above key levels.

D
GLD
DiscoverGold DiscoverGold 2 minutos hace
Gold Tests Trendline Resistance Amidst Bearish Channel Pressures
By: Bruce Powers | January 1, 2025

• Gold tests resistance at the declining trendline, but bearish pressures persist as the downtrend remains intact without a clear breakout above key levels.

D
GOLD
ORCA ORCA 3 minutos hace
I HATE SHORT SELLERS.I AM THEIR ENEMY.ALL THESE YEARS.I NEVER PLAYED SHORT EVER.WAY TOO MUCH RISK.
ESPECIALLY IN PENNY STOCKS.I AM JUST A FLIPPER.FOR CHICKEN TRIOS:))
AXXA
cableguy cableguy 3 minutos hace
Lol... ASII eom...
ASII
DiscoverGold DiscoverGold 4 minutos hace
Crude Oil Surges Past Swing High, Targets Fibonacci Levels
By: Bruce Powers | January 1, 2025

• Crude oil’s breakout signals strength as it targets higher resistance zones, with key technical levels and bullish patterns guiding its upward trajectory.

Crude o
OILBRENT
cableguy cableguy 5 minutos hace
Lol... that would be me back in the day, looks like I have to school Jim Carry, the center conductor is way too long, LoL... ASII
ASII
gawti88 gawti88 5 minutos hace
Kates gone! We all got what we wanted!

Party time! Smooth run up to 25c+
CEOS
DiscoverGold DiscoverGold 6 minutos hace
Natural Gas Faces Pressure After Reaching Key Resistance Levels
By: Bruce Powers | January 1, 2025

• Bearish signals intensify for natural gas as resistance holds, putting key levels like the 20-Day MA and recent 3.29 low at risk.

Natural gas weakened furth
OILBRENT
europa7 europa7 6 minutos hace
Block Time Financial and Stellar

https://blocktimefinancial.com/partners/ ~ (see listing of Stellar)
https://blocktimefinancial.com/about-us/
https://blocktimefinancial.com/news/ ~ (see Stellar news items)
https://blocktimefinancial.com/use-cases/
https
JPM
fink fink 7 minutos hace
He needs to get on ivermectin
Even the apple horse past from tractor supply is a must have. First hint of the flu. 1/10 dose for 10 days.
AZRH
NITE/$TOCKER NITE/$TOCKER 7 minutos hace
https://www.facebook.com/share/r/1EueYZYRmv/?mibextid=wwXIfr
XRPUSD
ShawnP123 ShawnP123 7 minutos hace
Just noticed on Morningstar in the top 20 funds there was a decline of 2M shares and in the top 20 institutions there was a decline of 4M shares. Just have a strong feeling January will not be a good month for SP.
NVDA
cowtown jay cowtown jay 8 minutos hace
The pieces just keep falling into place, DTG. I am super excited!
tuzedaze tuzedaze 8 minutos hace
New short rule starts tomorrow…. Will it help FNMA and FMCC???

https://www.acaglobal.com/insights/new-sec-rule-short-selling-key-filing-requirements-and-deadlines-form-sho#:~:text=Starting%20January%202%2C%202025%2C%20managers,manipulation%20and%20mitigate%20systemic%20risks.
FMCC
Manspider Manspider 8 minutos hace
Let’s get this thing chugging in 2025!! Lots of great news! :-D
ASII
DiamondHealer95 DiamondHealer95 8 minutos hace
Hello,

1 metric ton means nothing as Kim stated we won't be open for business until 1.5 metric tons.

Be well, base yourself in reality before posting.

Blessings -DH
KBLB
DiamondHealer95 DiamondHealer95 9 minutos hace
No, he didn't. He said he wanted to finance 5 million for sales and marketing. Not production.

Blessings, -DH
KBLB
chklingon chklingon 10 minutos hace
ROFL.... The legacy auto companies do not want to let go of their ICE sales. So.... enter the Hybrid. I drove a Prius for years, great car. It saved me a bundle on my travels. However time and technology has moved on. My Tesla MY is way better, quicker and saves me money each month over the well mad
TSLA
janice shell janice shell 10 minutos hace
Trump fought and won the election by a landslide.

Only if you've invented a brand new definition for "landslide". As Blackhawks pointed out, Trump won with 49.8 to Harris's 48.3. That is not a landslide.

Trumpty is a "finely tuned machine"?? What does this machine do,
DiamondHealer95 DiamondHealer95 11 minutos hace
It seems everyone is focused on sales regarding Kim's request for financing. This is a fundamental mistake.

1. They're 500k or more in actual debt.
2. Marketing. As I've said for quite some time now, they need to market, advertise, and be present in more places than just th
KBLB
Autophagy Autophagy 11 minutos hace
https://www.reddit.com/r/Shortsqueeze/comments/1hrhl62/anavex_life_sciences_avxl_the_short_squeeze_that/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
AVXL
meirluc meirluc 11 minutos hace
"There is a very real chance NWBO never submits a BLA for DCVax-L.
They have never, not once, said anything about plans to submit to the FDA."

I also do not recall that NWBO mentioned its intention to submit applications to
the EU. If that fact can be taken as evidence
NWBO

Su Consulta Reciente

Delayed Upgrade Clock